{"id":24175,"date":"2024-05-10T16:03:19","date_gmt":"2024-05-10T20:03:19","guid":{"rendered":"https:\/\/www.mesotheliomahope.com\/?page_id=24175"},"modified":"2025-06-23T20:47:41","modified_gmt":"2025-06-24T00:47:41","slug":"durvalumab","status":"publish","type":"page","link":"https:\/\/www.mesotheliomahope.com\/treatment\/immunotherapy\/durvalumab\/","title":{"rendered":"Durvalumab (Imfinzi\u00ae)"},"content":{"rendered":"

What Is Imfinzi\u00ae<\/sup> (Durvalumab) for Mesothelioma?<\/h2>\n

Durvalumab, also known as Imfinzi, is a type of mesothelioma immunotherapy<\/a>\u00a0made by the company AstraZeneca.<\/p>\n

Immunotherapy medications boost the body\u2019s natural immune response to cancers like mesothelioma. Durvalumab belongs to a class of medications known as immune checkpoint inhibitors<\/a> and works by targeting a protein called PD-L1, which is found on the surface of cancer cells.<\/p>\n

The mesothelioma cells use PD-L1 to avoid destruction by T-cells (which the immune system makes to kill cancer). However, thanks to durvalumab, the T-cells can start fighting mesothelioma<\/a>.<\/p>\n

Key Facts on Durvalumab Immunotherapy for Mesothelioma<\/h3>\n
    \n
  • Brand name:<\/strong> Imfinzi<\/li>\n
  • Combined treatments:<\/strong> Chemotherapy, surgery, and other immunotherapies<\/li>\n
  • Delivery method:<\/strong> Intravenous (IV) infusion<\/li>\n
  • Common side effects:<\/strong> Fatigue, nausea, numbness\/tingling, and skin rashes<\/li>\n
  • Life expectancy after therapy:<\/strong> 2 years or more when used with other treatments<\/li>\n<\/ul>\n

    Download our Free Immunotherapy Guide<\/strong> to learn how durvalumab and other types of mesothelioma immunotherapy drugs could help you.<\/p>\n